Leslie I. Rose

1.8k total citations
71 papers, 1.3k citations indexed

About

Leslie I. Rose is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Leslie I. Rose has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Reproductive Medicine and 13 papers in Molecular Biology. Recurrent topics in Leslie I. Rose's work include Hormonal and reproductive studies (15 papers), Ovarian function and disorders (12 papers) and Hormonal Regulation and Hypertension (11 papers). Leslie I. Rose is often cited by papers focused on Hormonal and reproductive studies (15 papers), Ovarian function and disorders (12 papers) and Hormonal Regulation and Hypertension (11 papers). Leslie I. Rose collaborates with scholars based in United States. Leslie I. Rose's co-authors include Gordon H. Williams, Robert G. Dluhy, Kenneth H. Cooper, Stephen R. Newmark, Jeffrey L. Miller, Peter E. Pochi, Stephen L. Lowe, David P. Lauler, Eric W. Peterson and Elliot J. Rayfield and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

Leslie I. Rose

71 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie I. Rose United States 21 542 301 254 164 149 71 1.3k
Margaret Peterson United States 15 422 0.8× 290 1.0× 321 1.3× 189 1.2× 113 0.8× 28 1.4k
L. M. Demers United States 22 427 0.8× 353 1.2× 334 1.3× 51 0.3× 227 1.5× 30 1.4k
Mark Stene United States 16 598 1.1× 306 1.0× 349 1.4× 146 0.9× 103 0.7× 23 1.2k
Erol Bolu Türkiye 20 508 0.9× 263 0.9× 240 0.9× 81 0.5× 85 0.6× 55 1.3k
Jamshid Alaghband‐Zadeh United Kingdom 24 497 0.9× 359 1.2× 236 0.9× 153 0.9× 232 1.6× 73 1.7k
K Vondra Czechia 21 567 1.0× 240 0.8× 518 2.0× 186 1.1× 335 2.2× 106 1.5k
P J Pringle United Kingdom 24 802 1.5× 327 1.1× 207 0.8× 93 0.6× 80 0.5× 47 1.3k
Hélène Leblanc France 15 731 1.3× 131 0.4× 251 1.0× 366 2.2× 95 0.6× 42 1.4k
James P. Gutai United States 21 1.0k 1.9× 332 1.1× 303 1.2× 56 0.3× 267 1.8× 36 2.0k
H. K. Kley Germany 18 737 1.4× 249 0.8× 205 0.8× 43 0.3× 56 0.4× 62 1.2k

Countries citing papers authored by Leslie I. Rose

Since Specialization
Citations

This map shows the geographic impact of Leslie I. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie I. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie I. Rose more than expected).

Fields of papers citing papers by Leslie I. Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie I. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie I. Rose. The network helps show where Leslie I. Rose may publish in the future.

Co-authorship network of co-authors of Leslie I. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie I. Rose. A scholar is included among the top collaborators of Leslie I. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie I. Rose. Leslie I. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rose, Leslie I., et al.. (2001). Anticardiolipin Antibodies In Hashimoto’S Disease. Endocrine Practice. 7(3). 181–183. 20 indexed citations
2.
Rose, Leslie I., et al.. (1999). Successful Therapy for a Mixed Thyrotropin- and Prolactin-Secreting Pituitary Macroadenoma With Cabergoline. Endocrine Practice. 5(2). 76–79. 13 indexed citations
3.
Telang, Gladys H., et al.. (1997). Testosterone concentrations and oligomenorrhea in women with acne. International Journal of Dermatology. 36(11). 845–847. 6 indexed citations
4.
Mozley, P. David, et al.. (1996). Failure of Adrenal Scintigraphy to Exhibit 131I Cholesterol Uptake in a CT-Demonstrated, Surgically Proven Aldosteronoma. The American Journal of the Medical Sciences. 312(3). 130–132. 3 indexed citations
5.
Derogatis, Leonard R., et al.. (1993). Serum androgens and psychopathology in hirsute women. Journal of Psychosomatic Obstetrics & Gynecology. 14(4). 269–282. 7 indexed citations
6.
Miller, Jeffrey L., et al.. (1993). Bedtime insulin added to daytime sulfonylureas improves glycemic control in uncontrolled type II diabetes. Clinical Pharmacology & Therapeutics. 53(3). 380–384. 2 indexed citations
7.
Spielvogel, Richard L., et al.. (1992). Serum androstanediol glucuronide in women with facial hirsutism. Journal of the American Academy of Dermatology. 26(3). 411–414. 6 indexed citations
8.
Derogatis, Leonard R., et al.. (1992). Serum androgens and depression in women with facial hirsutism. Journal of the American Academy of Dermatology. 27(2). 178–181. 37 indexed citations
9.
Spielvogel, Richard L., et al.. (1991). Androgens and oligomenorrhea in hirsute women. Journal of the American Academy of Dermatology. 24(3). 423–425. 2 indexed citations
10.
Rose, Leslie I., et al.. (1989). Corticosteroids and Adrenal Suppression. Drugs. 38(5). 838–845. 20 indexed citations
11.
Miller, Jeffrey L., et al.. (1988). Side-Effects of Spironolactone Therapy in the Hirsute Woman. The Journal of Clinical Endocrinology & Metabolism. 66(1). 208–211. 58 indexed citations
12.
Rose, Leslie I., et al.. (1985). Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function. The American Journal of Medicine. 78(3). 443–450. 67 indexed citations
13.
Liu, Linda, et al.. (1984). Recurrent Thyrotoxicosis After I-131 Induced Hypothyroidism. Clinical Nuclear Medicine. 9(1). 15–16. 1 indexed citations
14.
Nestico, Pasquale F., Nicholas L. DePace, Morris N. Kotler, et al.. (1983). Calcium phosphorus metabolism in dialysis patients with and without mitral anular calcium. The American Journal of Cardiology. 51(3). 497–500. 33 indexed citations
15.
Rose, Leslie I., et al.. (1979). The Partial Adrenocortical Hydroxylase Deficiency Syndrome in Infertile Women. Fertility and Sterility. 32(5). 536–541. 19 indexed citations
16.
Newmark, Stephen R., et al.. (1979). Gonadotropin profiles in fed and fasted obese women. American Journal of Obstetrics and Gynecology. 133(1). 75–80. 20 indexed citations
17.
Hirsh, Leonard F., et al.. (1978). Panhypopituitarism resulting from hodgkin's disease of the nasopharynx. Cancer. 41(3). 1134–1136. 16 indexed citations
18.
Birk, Lee, et al.. (1973). Serum Testosterone Levels in Homosexual Men. New England Journal of Medicine. 289(23). 1236–1238. 25 indexed citations
19.
Rayfield, Elliot J., Leslie I. Rose, Robert G. Dluhy, & Gordon H. Williams. (1973). Aldosterone Secretory and Glucocorticoid Excretory Responses to Alpha 1-24 ACTH (Cortrosyn) in Sodium-Depleted Normal Man. The Journal of Clinical Endocrinology & Metabolism. 36(1). 30–35. 29 indexed citations
20.
Rayfield, Elliot J., Leslie I. Rose, John P. Cain, Robert G. Dluhy, & Gordon H. Williams. (1971). ACTH-Responsive, Dexamethasone-Suppressible Adrenocortical Carcinoma. New England Journal of Medicine. 284(11). 591–592. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026